Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

NCT07326930

Conditions: Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China

Shanghai Children's Medical Center Shanghai, China

Shenzhen Children's Hospital Shenzhen, China

View Trial Details

Recruiting

Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse

NCT06910124

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

NCT04872478

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +14 more
Locations: Emory University - WINSHIP Cancer Center Atlanta, Georgia, United States

Emory University, Children's Healthcare of Atlanta Atlanta, Georgia, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.

NCT07327138

Conditions: Acute Lymphoblastic Leukemia ALL, Agnosia, Cancer Pain, +18 more
Locations: Hammoud Hospital University Medical Center Sidon, Lebanon

View Trial Details

Recruiting

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

NCT06043674

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Winship Cancer Institute at Emory University Atlanta, Georgia, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

NCT05417165

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Pharmacokinetics of Drugs Administered to Children

NCT03481881

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Recruiting

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

NCT06510894

Conditions: Cardiac Sarcoidosis, Hemic and Lymphatic Diseases, Hypersensitivity, +5 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors

NCT06365671

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Recruiting

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

NCT07108998

Conditions: CLL, CLL/SLL, Chronic Disease, +20 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions